Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease clinical trial (NCT05800275). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from the treatments in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease clinical trial (NCT05800275). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to visit the clinic for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease clinical trial (NCT05800275). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects or my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease clinical trial (NCT05800275). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any other treatment options available for my condition that I should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease clinical trial (NCT05800275). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my overall health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease clinical trial (NCT05800275). Contact the study team or your healthcare provider for specific answers.

What this study is about